Balasubramanian Priyavadhana, Ramteke Prashant, Mallick Saumyaranjan, Kumar Lalit, Tanwar Pranay
Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, New Delhi, India.
Department of Pathology, All India Institute of Medical Sciences, New Delhi, New Delhi, India.
Clin Med Insights Blood Disord. 2019 Jan 15;12:1179545X18821160. doi: 10.1177/1179545X18821160. eCollection 2019.
Diffuse large B-cell lymphoma (DLBCL) accounts for 30% to 40% of the newly diagnosed adult non-Hodgkin lymphomas, but rarely presents in leukaemic phase. Here in, we report a case of DLBCL presenting in leukaemic phase and masquerading as acute leukaemia. A 28-year-old woman presented to our outpatient department with complaints of fever for 1 week. Her peripheral blood smear showed 5% to 8% blasts. Bone marrow aspirate showed an infiltration by ~30% blasts. Flow cytometry and immunohistochemistry confirmed relapse of DLBCL. Also, patient's poor response to therapeutic regimen for DLBCL prompted to consider second differential diagnosis of acute leukaemia. This case is a learning case, as it emphasizes the combined role of diagnostic ancillary techniques along with clinical judgments for management. The case also makes us more vigilant towards the pathobiology of DLBCL and dynamics of personalized individual treatment response.
弥漫性大B细胞淋巴瘤(DLBCL)占新诊断的成人非霍奇金淋巴瘤的30%至40%,但很少以白血病期出现。在此,我们报告一例以白血病期表现并伪装为急性白血病的DLBCL病例。一名28岁女性因发热1周前来我院门诊就诊。她的外周血涂片显示5%至8%的原始细胞。骨髓穿刺显示约30%的原始细胞浸润。流式细胞术和免疫组化证实为DLBCL复发。此外,患者对DLBCL治疗方案反应不佳促使考虑急性白血病的第二种鉴别诊断。该病例具有学习意义,因为它强调了诊断辅助技术与临床判断在管理中的联合作用。该病例也使我们对DLBCL的病理生物学和个性化个体治疗反应动态更加警惕。